Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 12/20 | 0.52 |
| ▸ | HSD17B2 | P37059 | 10/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAPDH | P04406 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4779452 | 0.84 | HSD17B1 (0.64) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL9739121 | 0.82 | HSD17B1 (0.47) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL3680161 | 0.82 | HSD17B1 (0.61) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL5050883 | 0.80 | HSD17B1 (0.58) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL17051267 | 0.80 | HSD17B1 (0.58) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL2186104 | 0.78 | ALDH1A1 (0.62) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL31344495 | 0.78 | ALDH1A1 (0.62) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL4651426 | 0.78 | HSD17B1 (0.56) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL31344497 | 0.78 | ALDH1A1 (0.62) | HSD17B1HSD17B2CYP3A4CYP2C9CA12 | |
| SCHEMBL28639034 | 0.78 | MEN1 (0.45) | ALDH1A1LMNAESR1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116234395-A | Perovskite solar cell and preparation method thereof | 宣城先进光伏技术有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-114478336-B | Process for producing mercaptophenol compound and intermediate therefor | 组合化学工业株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-116234395-A | Perovskite solar cell and preparation method thereof | 宣城先进光伏技术有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-113195909-B | Charging roller and image forming apparatus | 株式会社亚科迈 | 2023-06-02 | — | — | CN | disclosed |
| CN-113234186-A | Preparation method of modified hydroxyl-terminated polybutadiene polymer | 中国船舶重工集团公司第七二五研究所 | 2021-08-10 | — | — | CN | disclosed |
| US-7807713-B2 | Pan-antagonists for the androgen receptor and androgen associated with anti-androgen withdrawal | UNIVERSITY OF DELAWARE (US) | 2010-10-05 | — | — | US | disclosed |
| US-20090270512-A1 | Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-10-29 | — | — | US | disclosed |
| US-7550505-B2 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | UNIVERSITY OF DELAWARE (US) | 2009-06-23 | — | — | US | disclosed |
| US-20080064757-A1 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-03-13 | — | — | US | disclosed |
| WO-2008013791-A2 | PAN-ANTAGONISTS FOR THE ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR MUTANTS ASSOCIATED WITH ANTI-ANDROGEN WITHDRAWAL | UNIVERSITY OF DELAWARE (US) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270512-A1 | Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal | AR, NR5A1, SHBG | HSD17B1 24/4885HSD17B2 16/4885CYP3A4 2306/4885 |
| US-20080064757-A1 | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal | AR, NR5A1, SHBG | HSD17B1 24/4885HSD17B2 16/4885CYP3A4 2306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.